Publication | Closed Access

Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats

Hami 3379PharmacotherapyFocal Cerebral IschemiaAcute Brain InjuryCerebral Vascular RegulationNeuroinflammationInflammationBrain InjuryNeurologyIschemic SyndromeMedicineNeuropharmacologyVascular BiologyNeuroprotectionCerebral Blood FlowReperfusion InjuryPharmacologyNeuroscienceStroke